Vilacto Bio Inc.
CIK 0001576724
Revenue (TTM)
$7.81K
+242.5% YoY
Q1 Aug 2019
Net Income (TTM)
−$5.95M
−779.8% YoY
Q1 Aug 2019
EPS Diluted (TTM)
—
Q1 Aug 2019
Gross Margin
26.0%
Q1 Aug 2019
Operating Margin
-10,876.8%
Q1 Aug 2019
Net Margin
-76,275.5%
Q1 Aug 2019
Free Cash Flow (TTM)
—
Q1 Aug 2019
Cash
$120.73K
Q1 Aug 2019
Total Debt
—
Q1 Aug 2019
Shares Outstanding
2.14B sh
Q1 Aug 2019